GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | 8/14/2026 6:45:56 AM | View | Financials | Earnings | WIRE | 2Q 2026 | Rev $0 | Assets $65,973,000 | EPS -$0.10 | Export Earnings Model | |
| Rein Therapeutics, Inc. (RNTX) | 8/14/2026 6:43:08 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $65,973,000 | EPS -$0.10 | ||
| Rein Therapeutics, Inc. (RNTX) | 6/8/2026 9:18:30 AM | View | Proxy | SEC | Y 2025 | ||||||
| Rein Therapeutics, Inc. (RNTX) | 5/15/2026 8:01:26 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $26,288,000 | EPS -$0.19 | ||
| Rein Therapeutics, Inc. (RNTX) | 4/27/2026 7:01:50 AM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Assets $24,158,000 | EPS -$1.96 | ||
| Rein Therapeutics, Inc. (RNTX) | 3/26/2026 4:45:04 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $24,158,000 | EPS -$1.96 | ||
| Rein Therapeutics, Inc. (RNTX) | 11/14/2025 8:13:22 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $53,706,000 | EPS -$0.21 | ||
| Rein Therapeutics, Inc. (RNTX) | 8/14/2025 4:15:14 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $57,479,000 | EPS -$0.28 | ||
| Rein Therapeutics, Inc. (RNTX) | 5/15/2025 4:22:27 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $0 | Assets $57,628,000 | EPS -$0.25 | Export Earnings Model | |
| Rein Therapeutics, Inc. (RNTX) | 5/15/2025 4:13:56 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $57,628,000 | EPS -$0.25 | ||
| Rein Therapeutics, Inc. (RNTX) | 5/12/2025 4:30:54 PM | View | Proxy | SEC | Y 2024 | ||||||
| Rein Therapeutics, Inc. (RNTX) | 4/30/2025 5:35:53 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Assets $62,190,000 | EPS -$3.51 | ||
| Rein Therapeutics, Inc. (RNTX) | 4/7/2025 4:18:41 PM | View | Financials | Earnings | WIRE | 1Q 2025 | Rev $0 | Assets $57,628,000 | EPS -$0.25 | Export Earnings Model | |
| Rein Therapeutics, Inc. (RNTX) | 4/7/2025 4:13:53 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $62,190,000 | EPS -$3.51 | ||
| Aileron Therapeutics, Inc. (RNTX) | 11/14/2024 4:15:09 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $0 | Assets $104,217,000 | EPS -$0.27 | Export Earnings Model | |
| Aileron Therapeutics, Inc. (RNTX) | 11/14/2024 4:14:53 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $104,217,000 | EPS -$0.27 | ||
| Aileron Therapeutics, Inc. (RNTX) | 8/14/2024 5:26:38 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $109,400,000 | EPS -$0.45 | ||
| Aileron Therapeutics, Inc. (RNTX) | 8/14/2024 5:25:09 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $0 | Assets $109,400,000 | EPS -$0.45 | Export Earnings Model | |
| Aileron Therapeutics, Inc. (RNTX) | 7/9/2024 8:31:53 AM | View | Proxy | SEC | Y 2023 | ||||||
| Aileron Therapeutics, Inc. (RNTX) | 5/15/2024 5:19:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $99,192,000 | EPS -$0.86 | ||
| Aileron Therapeutics, Inc. (RNTX) | 5/15/2024 5:17:25 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $0 | Assets $99,192,000 | EPS -$0.86 | Export Earnings Model | |
| Aileron Therapeutics, Inc. (RNTX) | 5/1/2024 8:42:37 AM | View | Financials | Earnings (Prelim) | SEC | 1Q 2024 | Export Earnings Model | ||||
| Aileron Therapeutics, Inc. (RNTX) | 4/29/2024 8:47:02 AM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Assets $106,008,000 | EPS -$3.42 | ||
| Aileron Therapeutics, Inc. (RNTX) | 4/15/2024 5:36:56 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $106,008,000 | EPS -$3.42 | ||
| Aileron Therapeutics, Inc. (RNTX) | 4/15/2024 5:24:04 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $0 | Assets $106,008,000 | EPS -$1.57 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 1/29/2024 8:48:27 AM | View | Proxy | SEC | Y 2023 | ||||||
| AILERON THERAPEUTICS INC (RNTX) | 10/13/2023 4:17:01 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $12,822,000 | EPS -$0.40 | ||
| AILERON THERAPEUTICS INC (RNTX) | 8/11/2023 4:15:34 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $13,991,000 | EPS -$0.39 | ||
| AILERON THERAPEUTICS INC (RNTX) | 5/8/2023 8:10:07 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $17,157,000 | EPS -$1.05 | ||
| AILERON THERAPEUTICS INC (RNTX) | 4/28/2023 8:12:01 AM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Assets $22,007,000 | EPS -$6.02 | ||
| AILERON THERAPEUTICS INC (RNTX) | 3/20/2023 4:30:34 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $22,007,000 | EPS -$6.02 | ||
| AILERON THERAPEUTICS INC (RNTX) | 11/1/2022 8:47:38 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $27,232,000 | EPS -$1.40 | ||
| Aileron Therapeutics Inc (RNTX) | 11/1/2022 8:17:07 AM | View | Financials | Earnings | WIRE | 3Q 2022 | Rev $0 | Assets $27,232,000 | EPS -$1.40 | Export Earnings Model | |
| Aileron Therapeutics Inc (RNTX) | 8/15/2022 4:31:47 PM | View | Financials | Earnings | WIRE | 2Q 2022 | Rev $0 | Assets $33,770,000 | EPS -$1.76 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 8/15/2022 4:26:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $33,770,000 | EPS -$1.76 | ||
| AILERON THERAPEUTICS INC (RNTX) | 5/5/2022 5:28:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $40,255,000 | EPS -$1.86 | ||
| Aileron Therapeutics Inc (RNTX) | 5/5/2022 4:16:54 PM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $0 | Assets $40,255,000 | EPS -$1.86 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 4/29/2022 4:48:12 PM | View | Proxy | SEC | Y 2021 | ||||||
| Aileron Therapeutics Inc (RNTX) | 3/28/2022 4:22:39 PM | View | Financials | Earnings | WIRE | Y 2021 | Rev $0 | Assets $48,481,000 | EPS -$5.67 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 3/28/2022 4:15:44 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $48,481,000 | EPS -$5.89 | ||
| Aileron Therapeutics Inc (RNTX) | 11/12/2021 7:52:13 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Rev $0 | Assets $54,768,000 | EPS -$0.07 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 11/12/2021 7:15:13 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $54,768,000 | EPS -$0.07 | ||
| Aileron Therapeutics Inc (RNTX) | 8/11/2021 4:22:32 PM | View | Financials | Earnings | WIRE | 2Q 2021 | Rev $0 | Assets $60,531,000 | EPS -$0.06 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 8/11/2021 4:11:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $60,531,000 | EPS -$0.06 | ||
| Aileron Therapeutics Inc (RNTX) | 5/11/2021 4:19:55 PM | View | Financials | Earnings | WIRE | 1Q 2021 | Rev $0 | Assets $64,671,000 | EPS -$0.08 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 5/11/2021 4:13:41 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $64,671,000 | EPS -$0.08 | ||
| AILERON THERAPEUTICS INC (RNTX) | 4/28/2021 5:00:06 PM | View | Proxy | SEC | Y 2020 | ||||||
| AILERON THERAPEUTICS INC (RNTX) | 3/24/2021 4:43:37 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $16,341,000 | EPS -$0.61 | ||
| Aileron Therapeutics Inc (RNTX) | 3/24/2021 4:39:24 PM | View | Financials | Earnings | WIRE | Y 2020 | Rev $0 | Assets $16,341,000 | EPS -$0.12 | Export Earnings Model | |
| Aileron Therapeutics Inc (RNTX) | 11/12/2020 7:04:50 PM | View | Financials | Earnings | WIRE | 3Q 2020 | Rev $0 | Assets $22,239,000 | EPS -$0.13 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 11/12/2020 4:15:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $22,239,000 | EPS -$0.13 | ||
| AILERON THERAPEUTICS INC (RNTX) | 8/5/2020 4:19:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $26,125,000 | EPS -$0.14 | ||
| Aileron Therapeutics Inc (RNTX) | 8/5/2020 4:16:31 PM | View | Financials | Earnings | WIRE | 2Q 2020 | Rev $0 | Assets $26,125,000 | EPS -$0.14 | Export Earnings Model | |
| Aileron Therapeutics Inc (RNTX) | 5/11/2020 8:31:23 AM | View | Financials | Earnings | WIRE | 1Q 2020 | Rev $0 | Assets $20,373,000 | EPS -$0.24 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 5/11/2020 8:16:13 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $20,373,000 | EPS -$0.24 | ||
| AILERON THERAPEUTICS INC (RNTX) | 4/28/2020 5:09:52 PM | View | Proxy | SEC | Y 2019 | ||||||
| Aileron Therapeutics Inc (RNTX) | 3/30/2020 4:18:54 PM | View | Financials | Earnings | WIRE | Y 2019 | Rev $0 | Assets $26,473,000 | EPS -$0.26 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 3/30/2020 4:14:35 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $26,473,000 | EPS -$1.20 | ||
| Aileron Therapeutics Inc (RNTX) | 11/7/2019 7:31:27 AM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $0 | Assets $33,952,000 | EPS -$0.28 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 11/7/2019 7:05:16 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $33,952,000 | EPS -$0.28 | ||
| AILERON THERAPEUTICS INC (RNTX) | 8/6/2019 4:28:33 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $40,193,000 | EPS -$0.26 | ||
| Aileron Therapeutics Inc (RNTX) | 8/6/2019 4:16:56 PM | View | Financials | Earnings | WIRE | 2Q 2019 | Rev $0 | Assets $40,193,000 | EPS -$0.26 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 5/8/2019 5:08:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $22,399,000 | EPS -$0.49 | ||
| Aileron Therapeutics Inc (RNTX) | 5/8/2019 4:59:07 PM | View | Financials | Earnings | WIRE | 1Q 2019 | Rev $0 | Assets $22,399,000 | EPS -$0.49 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 4/30/2019 5:37:25 PM | View | Proxy | SEC | Y 2018 | ||||||
| AILERON THERAPEUTICS INC (RNTX) | 3/29/2019 6:33:14 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $30,312,000 | EPS -$2.14 | ||
| AILERON THERAPEUTICS INC (RNTX) | 11/7/2018 4:23:06 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $38,133,000 | EPS -$0.50 | ||
| Aileron Therapeutics Inc (RNTX) | 11/7/2018 4:16:01 PM | View | Financials | Earnings | WIRE | 3Q 2018 | Rev $0 | Assets $38,133,000 | EPS -$0.50 | Export Earnings Model | |
| AILERON THERAPEUTICS INC (RNTX) | 8/7/2018 4:15:53 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $42,577,000 | EPS -$0.64 | ||
| AILERON THERAPEUTICS INC (RNTX) | 5/9/2018 4:55:01 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $45,831,000 | EPS -$0.52 | ||
| AILERON THERAPEUTICS INC (RNTX) | 4/30/2018 8:01:26 AM | View | Proxy | SEC | Y 2017 | ||||||
| AILERON THERAPEUTICS INC (RNTX) | 4/2/2018 4:24:00 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $52,688,000 | EPS -$3.04 | ||
| AILERON THERAPEUTICS INC (RNTX) | 11/9/2017 4:37:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $59,036,000 | EPS -$0.45 | ||
| AILERON THERAPEUTICS INC (RNTX) | 8/10/2017 4:16:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $15,105,000 | EPS -$10.98 |